Possible Harms of Theophylline in Chronic Obstructive Pulmonary Disease

por Vogelmeier, Claus F
Publicado 2014

Systemic steroids in COPD-the beauty and the beast

por Vogelmeier, Claus F
Publicado en Respir Res (2014)

Alpha-1-antitrypsin deficiency: increasing awareness and improving diagnosis

por Greulich, Timm, Vogelmeier, Claus F.
Publicado en Ther Adv Respir Dis (2015)

Health status in patients with COPD treated with roflumilast: two large noninterventional real-life studies: DINO and DACOTA

por Kardos, Peter, Mokros, Ingo, Sauer, Rüdiger, Vogelmeier, Claus F
Publicado en Int J Chron Obstruct Pulmon Dis (2018)

COPD & COVID-19

por Halpin, David M.G., Vogelmeier, Claus F., Agusti, Alvar A.
Publicado en Arch Bronconeumol (2021)

COPD & COVID-19

por Halpin, David M.G., Vogelmeier, Claus F., Agusti, Alvar A.
Publicado en Arch Bronconeumol (2021)

Excess Costs of Comorbidities in Chronic Obstructive Pulmonary Disease: A Systematic Review

por Huber, Manuel B., Wacker, Margarethe E., Vogelmeier, Claus F., Leidl, Reiner
Publicado en PLoS One (2015)

Tiotropium and Salmeterol in COPD Patients at Risk of Exacerbations: A Post Hoc Analysis from POET-COPD(®)

por Vogelmeier, Claus F., Asijee, Guus M., Kupas, Katrin, Beeh, Kai M.
Publicado en Adv Ther (2015)

Comorbid Influences on Generic Health-Related Quality of Life in COPD: A Systematic Review

por Huber, Manuel B., Wacker, Margarethe E., Vogelmeier, Claus F., Leidl, Reiner
Publicado en PLoS One (2015)

Chronisch-obstruktive Lungenerkrankung 2021 – die richtige Therapie für den richtigen Patienten

por Olschewski, Horst, Buhl, Roland, Funk, Georg Christian, Valipour, Arschang, Vogelmeier, Claus F.
Publicado en Internist (Berl) (2021)

Influence of body mass on predicted values of static hyperinflation in COPD

por Alter, Peter, Rabe, Klaus F, Schulz, Holger, Vogelmeier, Claus F, Jörres, Rudolf A
Publicado en Int J Chron Obstruct Pulmon Dis (2018)

Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population

por Vestbo, Jørgen, Vogelmeier, Claus F, Small, Mark, Siddall, James, Fogel, Robert, Kostikas, Konstantinos
Publicado en Int J Chron Obstruct Pulmon Dis (2019)

Real world evaluation of a novel lateral flow assay (AlphaKit® QuickScreen) for the detection of alpha-1-antitrypsin deficiency

por Greulich, Timm, Rodríguez-Frias, Francisco, Belmonte, Irene, Klemmer, Andreas, Vogelmeier, Claus F., Miravitlles, Marc
Publicado en Respir Res (2018)

COPD Assessment Test Changes from Baseline Correlate with COPD Exacerbations: A Longitudinal Analysis of the DACCORD Observational Study

por Kardos, Peter, Vogelmeier, Claus F., Worth, Heinrich, Buhl, Roland, Obermoser, Victoria, Criée, Carl-Peter
Publicado en Lung (2020)

Dual bronchodilation vs triple therapy in the “real-life” COPD DACCORD study

por Buhl, Roland, Criée, Carl-Peter, Kardos, Peter, Vogelmeier, Claus F, Kostikas, Konstantinos, Lossi, Nadine S, Worth, Heinrich
Publicado en Int J Chron Obstruct Pulmon Dis (2018)

Efficacy of indacaterol/glycopyrronium versus salmeterol/fluticasone in current and ex-smokers: a pooled analysis of IGNITE trials

por Halpin, David M.G., Vogelmeier, Claus F., Mezzi, Karen, Gupta, Pritam, Kostikas, Konstantinos, Wedzicha, Jadwiga A.
Publicado en ERJ Open Res (2021)

High eosinophil blood counts are associated with a shorter length of hospital stay in exacerbated COPD patients – a retrospective analysis

por Greulich, Timm, Tüffers, Julia, Mager, Sina, Eder, Anna, Maxheim, Michael, Alter, Peter, Schmeck, Bernd, Vogelmeier, Claus F.
Publicado en Respir Res (2020)

Characterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trial

por Beeh, Kai M, Glaab, Thomas, Stowasser, Susanne, Schmidt, Hendrik, Fabbri, Leonardo M, Rabe, Klaus F, Vogelmeier, Claus F
Publicado 2013

A Non-Interventional Study of Tiotropium/Olodaterol versus Any Triple Combination Therapy for Chronic Obstructive Pulmonary Disease: The EVELUT(®) Study Protocol

por Buhl, Roland, Dreher, Michael, Korn, Stephanie, Taube, Christian, Stock, Christian, Zehendner, Christoph M, Kondla, Anke, Vogelmeier, Claus F
Publicado en Int J Chron Obstruct Pulmon Dis (2020)

SABINA: An Overview of Short-Acting β(2)-Agonist Use in Asthma in European Countries

por Janson, Christer, Menzies-Gow, Andrew, Nan, Cassandra, Nuevo, Javier, Papi, Alberto, Quint, Jennifer K., Quirce, Santiago, Vogelmeier, Claus F.
Publicado en Adv Ther (2020)